Fate Therapeutics, Inc.

FATE ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
DEF 14A Apr 26, 2024 DEF 14A
CORRESP Apr 25, 2024
UPLOAD Apr 24, 2024
S-3 Apr 18, 2024 S-3
PRE 14A Apr 16, 2024 PRE 14A
4 Mar 25, 2024 OWNERSHIP DOCUMENT
SC 13D/A Mar 25, 2024 SC 13D/A
8-K Mar 21, 2024 8-K
424B5 Mar 20, 2024 424B5
4 Mar 5, 2024 4
144 Mar 4, 2024
10-K Feb 26, 2024 10-K
8-K Feb 26, 2024 8-K
SC 13G/A Feb 13, 2024 SCHEDULE 13G/A
SC 13G Feb 12, 2024
SC 13G/A Feb 9, 2024 SEC SCHEDULE 13G
4 Feb 2, 2024 4
4 Feb 2, 2024 4
4 Feb 2, 2024 4
4 Feb 2, 2024 4
4 Jan 30, 2024 4
144 Jan 29, 2024
SC 13G Jan 25, 2024 FATE THERAPEUTICS INC
SC 13G/A Jan 24, 2024
SC 13G/A Jan 22, 2024
← Newer Page 7 of 35 · 855 filings Older →